All diabetes articles – Page 2
-
BusinessNovo Nordisk to axe 1000 jobs
Diabetes specialist is cutting costs in the face of increased competition
-
BusinessSanofi sues Merck & Co over biosimilars
Merck challenges insulin patents, but Sanofi claims infringement
-
ResearchSweet tear sensor could ease pain of diabetes
New non-invasive sensor could check blood glucose levels using tears
-
Research
Phthalate replacements linked to child health problems
Levels of two plasticisers in children found to correlate with higher blood pressure and insulin resistance
-
Research'Smart patch' set to deliver for diabetes patients
Stick-on patch with glucose responsive microneedles releases insulin automatically whenever it is needed
-
Business
Takeda offers $2.4bn to settle diabetes litigation
Aims to settle multiple outstanding lawsuits relating to Actos (pioglitazone) and bladder cancer
-
-
ResearchSeeing glucose through the skin
Technique could one day allow diabetics to manage their condition without drawing blood
-
-
Business
Judge slashes fines in drug safety case
Takeda and Eli Lilly’s $9 billion damages in diabetes trial reduced to $38 million
-
Business
Sanofi snaps up inhaled insulin licence
Deal gives Mannkind access to global manufacturing and distribution for recently-approved Afrezza
-
BusinessPrice caps provoke lawsuits from Indian pharma industry
New government controls on cardiovascular and diabetes drugs challenged by industry lobby groups
-
Business
Inhaled insulin approved in US
European committee recommends approval for generic long-acting insulin
-
BusinessMissing safety risk emails draw $9bn Actos fine
Judge finds absence of Takeda documentation in bladder cancer case ‘disturbing’
-
Business
AstraZeneca shells out $4.1bn for diabetes business
Bristol-Myers Squibb exits the diabetes field with plans to become a specialised biopharmaceutical company
-
Business
US turnaround on Avandia restrictions
Researchers accuse regulator of face-saving U-turn over diabetes medication safety
-
NewsIndian U-turn on diabetes drug ban
Suspension of cheap and popular medicine reversed but will now come with new safety warnings
-
Business
Judge reverses jury decision over $6.5m Takeda payout
Not enough evidence to link diabetes drug to bladder cancer, the company claims
-
Business
Generic Actos approved
Mylan, Ranbaxy and Teva have won US marketing approval for their generic versions of Actos diabetes tablets
- Previous Page
- Page1
- Page2
- Page3
- Next Page